Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review
L Fardet, T Généreau, JL Poirot, B Guidet, A Kettaneh… - Journal of infection, 2007 - Elsevier
OBJECTIVE: To describe the main features of severe strongyloidiasis in corticosteroid-treated
patients METHODS: We report on 3 cases of corticosteroid-treated patients with severe …
patients METHODS: We report on 3 cases of corticosteroid-treated patients with severe …
[PDF][PDF] Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
M Ziol, A Handra‐Luca, A Kettaneh, C Christidis… - …, 2005 - Wiley Online Library
Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its
assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive …
assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive …
Rapid regression of prolonged pagophagia after treatment of iron deficiency
C Sontag, A Kettaneh, O Fain, V Eclache… - … (Paris, France: 1983), 2001 - europepmc.org
Background Pica is an eating disorder characterized by the irrepressible and elective craving
for food and non-food substances. Pagophagia is a particular form characterized by an …
for food and non-food substances. Pagophagia is a particular form characterized by an …
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
F Kazemi, A Kettaneh, G N'kontchou, E Pinto… - Journal of …, 2006 - Elsevier
BACKGROUND/AIMS: Periodic endoscopic screening for oesophageal varices is recommended
in patients with cirrhosis, but might be limited to a subgroup of patients if a simple non-…
in patients with cirrhosis, but might be limited to a subgroup of patients if a simple non-…
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients
V de Lédinghen, C Douvin, A Kettaneh… - JAIDS Journal of …, 2006 - journals.lww.com
Background: Chronic hepatitis C in HIV-infected patients is an increasing cause of death
dependent on the development of liver fibrosis, which is currently assessed by liver biopsy …
dependent on the development of liver fibrosis, which is currently assessed by liver biopsy …
Corticosteroid‐induced clinical adverse events: frequency, risk factors and patient's opinion
L Fardet, A Flahault, A Kettaneh, KP Tiev… - British Journal of …, 2007 - academic.oup.com
Background More than 50 years after the introduction of corticosteroids, few studies have
focused on corticosteroid‐induced adverse events after long‐term systemic therapy. Objectives …
focused on corticosteroid‐induced adverse events after long‐term systemic therapy. Objectives …
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease
P Nahon, A Kettaneh, I Tengher-Barna, M Ziol… - Journal of …, 2008 - Elsevier
BACKGROUND/AIMS: The aim of this study was to assess the accuracy of liver stiffness
measurement (LSM) for the diagnosis of extensive fibrosis and cirrhosis in patients with …
measurement (LSM) for the diagnosis of extensive fibrosis and cirrhosis in patients with …
Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: the Fleurbaix Laventie Ville Sante II study
This study aimed to document for the first time in a general population of French children the
prevalence and levels of cardiovascular risk factors and to assess separately in boys and …
prevalence and levels of cardiovascular risk factors and to assess separately in boys and …
Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic …
…, L Janin‐Manificat, B Lafon, A Kettaneh… - Arthritis & …, 2016 - Wiley Online Library
Objective Findings from the WEGENT trial and other short‐term studies have suggested that
azathioprine (AZA) or methotrexate (MTX) could effectively maintain remission of …
azathioprine (AZA) or methotrexate (MTX) could effectively maintain remission of …
Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients
BACKGROUND/AIMS: FibroScan ® , a non-invasive procedure for the diagnosis of cirrhosis,
benefits only patients for which at least 10 valid shots are acquired. We investigated …
benefits only patients for which at least 10 valid shots are acquired. We investigated …